-(3)- discovery of a transfer of mitochondria from mesenchymal stromal cells towards AML cells. The transfer is stimulated by chemotherapy and increases ATP production by recipient AML cells to protect them from chemotherapy (Moschoi 2016. Blood. 128, 253).

-(4)- setting up a fluorescent dilution factor (FDF) in primary AML cells that correlates with the proliferation potential of the sample and its frequency in Leukemic stem cells and displays a pronostic value after 1 week of co-culture with MSCs (Griessinger 2016. Cancer Research. 76, 2082).

-(5)- original finding that the polycomb protein and stem cell marker BMI1 inhibits autophagy in CML cells through the repression of a new target, the CCNG2/cyclin G2 tumor suppressor gene (Mourgues 2015. Leukemia. 29, 1993).